Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead scraps a PhII/III study early as drug flops against ulcerative colitis
Endpoints
Wed, 09/21/16 - 10:53 pm
Tags:
Gilead Sciences, ulcerative colitis, clinical trials, GS-5745
Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers'
Yahoo/Benzinga
Wed, 09/21/16 - 10:51 pm
Tags:
Allergan, Gilead Sciences, M&A
This Hated Pharma Stock Has A Bright Future
Yahoo/Street Authority
Wed, 09/21/16 - 09:52 am
Tags:
Gilead Sciences
After Losing Medivation, Who Is Gilead Going After Next?
Forbes
Mon, 09/19/16 - 03:39 pm
Tags:
Medivation, Gilead Sciences, M&A, Puma Biotechnology, Kite Pharma, Incyte, Portola Pharmaceuticals
Gilead Sciences: It’s What I Do, Not What I Say
Barron's
Wed, 09/14/16 - 11:45 pm
Tags:
Gilead Sciences
Gilead Sciences, Inc. Can Fancy TESARO Inc for Acquisition
Bidness, ETC
Tue, 09/13/16 - 11:38 am
Tags:
Gilead Sciences, PARP inhibitors, Tesaro, M&A, niraparib
Gilead Sciences, Inc. a Takeover Target? It's Not as Crazy As It Sounds
Motley Fool
Mon, 09/12/16 - 09:34 am
Tags:
Gilead Sciences, M&A, JNJ, Novartis, Amgen, Pfizer, Merck
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
Tags:
biotech, Eli Lilly, solanezumab, Biogen, aducanumab, Kite Pharma, KTE-C19, Bluebird Bio, LentiGlobin, Sarepta Therapeutics, eteplirsen, Ophthotech, Fovista, Bristol-Myers Squibb, Opdvio, Acadia, Nuplazid, Celgene, GED-301, Gilead Sciences, M&A
GlaxoSmithKline gambles against Gilead with risky bet on two-drug HIV combos
Fierce Pharma
Wed, 09/7/16 - 09:37 am
Tags:
GSK, Gilead Sciences, HIV, Tivicay, Edurant, Janssen, ViiV
Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine
Stat/Pharmalot
Tue, 09/6/16 - 03:08 pm
Tags:
Gilead Sciences, hepatitis C, Ukraine, Doctors Without Borders
Departing Pharma CEOs Leave Waning Sales for Successors to Solve
Bloomberg
Fri, 09/2/16 - 11:27 am
Tags:
Pharma CEOs, Novo Nordisk, Lars Sorenson, Gilead Sciences, John Martin, Eli Lilly, John Lechleiter, GSK, Andrew Witty
Gilead Was Smart to Let Medivation Slip Through its Fingers
Yahoo/GuruFocus
Tue, 08/30/16 - 09:53 am
Tags:
Gilead Sciences, Medivation, Pfizer, Sanofi, M&A
Gilead: Forbes Is Salty Over The Vermont Initiative
Seeking Alpha
Mon, 08/29/16 - 04:09 pm
Tags:
Gilead Sciences, Vermont, hepatitis C, drug pricing
Gilead Sciences, Inc. to Extend Reach in HIV Drugs Market Via Truvada’s Approval
Bidness, ETC
Wed, 08/24/16 - 10:41 am
Tags:
Gilead Sciences, Truvada, HIV, Europe
Gilead tackles a big PhIII program for blockbuster hopeful filgotinib
Endpoints
Tue, 08/23/16 - 05:45 pm
Tags:
Gilead Sciences, filgotinib, rheumatoid arthritis
4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss
Barron's
Tue, 08/23/16 - 11:11 am
Tags:
biotech, M&A, Gilead Sciences, Sanofi, Medivation, Incyte, Biomarin, Tesaro, Seattle Genetics
Break Up Gilead Sciences? Not So Fast
Barron's
Fri, 08/19/16 - 11:46 am
Tags:
Gilead Sciences, HIV, hepatitis C
Medivation shares pop after report that at least five companies interested in deal
CNBC
Thu, 08/18/16 - 09:53 am
Tags:
Medivation, M&A, Merck, Sanofi, Gilead Sciences, Celgene, Pfizer
Gilead Sciences, Inc: Why A Split Up Is Much Needed For Turnaround Growth?
Bidness, ETC
Thu, 08/18/16 - 08:47 am
Tags:
Gilead Sciences, HIV, hepatitis C
Merck enters race for cancer drugmaker Medivation - sources
Reuters
Wed, 08/17/16 - 04:18 pm
Tags:
Merck, Medivation, M&A, Sanofi, Pfizer, Celgene, Gilead Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.